Small Molecular Medicines Market Analysis

Dear Colleagues,

The market for “small molecular medicines” continues to grow, because of the combination of the increasing use of these medicines to treat acute and chronic diseases, and the increasing needs of an ageing population.

Health spending worldwide is increasing above the allocated resources, putting pressure on the health sector’s budget. Medicine utilization studies, usually small molecular medicine market analyses, provide insights that allow policy makers, budget holders, and healthcare professionals to support them to provide prompt access to effective treatments when appropriate, to make sure that spending on medicines is affordable for the health sector, and to support innovation in long-term medicines by promoting a thriving and sustainable pharmaceutical sector.

We invite you to share your approaches and experiences in analyzing the small medicine(s) market at the institutional (primary/secondary care sectors), national, and international level regarding a medicine, a group of medicines, or even the entire array of medicines utilized over a period of time and the financial impact of their analyses. We hope this Special Issue will inspire other healthcare professionals to share their own analyses, adopt new approaches, and innovate to make improvements.

Prof. Dr. Stephen Chapman
Dr. Mohammed I. Aladul
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmacy is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.